Methylphenidate (Relexxii, Ritalin) — 2026 Medicare Part D coverage
methylphenidate — sold as Relexxii, Ritalin: 51 forms appear in Medicare Part D formularies for 2026. This page reports what plans filed with CMS; it does not recommend a plan.
Which plans in your county cover methylphenidate?
Pick a county to see every Medicare Advantage plan filed there and every stand-alone Part D plan in its region, with this drug's tier, restrictions and tier cost sharing.
How to read drug coverage
Tier is the cost-sharing tier the plan assigned the drug in its CMS formulary filing; lower tiers usually cost less. PA = prior authorization, ST = step therapy (try another drug first), QL = quantity limit. Not on formulary means the plan did not list this exact form; the plan may cover another strength or a formulary exception may be possible. Cost sharing is the plan's initial-coverage amount for the tier as filed with CMS; the deductible, the $2,100 annual out-of-pocket cap, the $35 insulin cap and negotiated prices for selected drugs can change what you actually pay. Formularies change during the year; the plan's formulary document and Medicare.gov govern.
What the star rating under each Medicare Advantage plan means
What the star rating means. CMS rates every Medicare Advantage contract (the "H" number in the plan ID — all plans under it share the rating) on a 1-to-5 scale each October, from about 40 measures of care quality, member experience, complaints and appeals, customer service and, for plans with drug coverage, drug safety and pricing. The 2026 rating is largely based on performance measured in 2024.
5 Excellent4 Above average3 Average2 Below average1 Poor
Not rated means CMS published no overall rating — usually a contract too new to be measured or with too few members ("not enough data"); it is not a low score. A 5-star contract can be joined outside the normal enrollment windows (the 5-star Special Enrollment Period, Dec 8 – Nov 30). Medicare.gov flags contracts rated below 3 stars for three years running as low-performing. Stars describe the contract's past performance as CMS measured it; they are not a recommendation, and they do not tell you whether a plan's network, drugs or costs fit you.
Forms and strengths in 2026 formularies
| Form | Formularies listing it | Most common tier | PA | ST | QL |
|---|---|---|---|---|---|
| methylphenidate HCl 10 MG Oral Tablet generic · RxCUI 1091150 | 328 (100%) | 2 | 111 | 0 | 260 |
| methylphenidate HCl 20 MG Oral Tablet generic · RxCUI 1091392 | 328 (100%) | 2 | 111 | 0 | 260 |
| methylphenidate HCl 5 MG Oral Tablet generic · RxCUI 1091497 | 328 (100%) | 2 | 111 | 0 | 260 |
| methylphenidate HCl 5 MG in 5 mL Oral Solution generic · RxCUI 1091341 | 265 (81%) | 4 | 91 | 0 | 213 |
| methylphenidate HCl 20 MG 8HR Extended Release Oral Tablet generic · RxCUI 1091225 | 250 (76%) | 4 | 107 | 0 | 183 |
| methylphenidate HCl 10 MG in 5 mL Oral Solution generic · RxCUI 1091133 | 249 (76%) | 4 | 91 | 0 | 213 |
| methylphenidate HCl 10 MG 8HR Extended Release Oral Tablet generic · RxCUI 1091145 | 234 (71%) | 4 | 96 | 0 | 169 |
| methylphenidate HCl 18 MG 24HR Extended Release Oral Tablet generic · RxCUI 1091155 | 104 (32%) | 2 | 3 | 0 | 62 |
| methylphenidate HCl 27 MG 24HR Extended Release Oral Tablet generic · RxCUI 1091170 | 104 (32%) | 2 | 3 | 0 | 62 |
| methylphenidate HCl 54 MG 24HR Extended Release Oral Tablet generic · RxCUI 1091210 | 104 (32%) | 2 | 3 | 0 | 62 |
| methylphenidate HCl 27 MG 24HR Extended Release Oral Tablet, BX Rating generic · RxCUI 2001565 | 102 (31%) | 2 | 3 | 0 | 64 |
| methylphenidate HCl 36 MG 24HR Extended Release Oral Tablet generic · RxCUI 1091185 | 102 (31%) | 2 | 3 | 0 | 60 |
| methylphenidate HCl 54 MG 24HR Extended Release Oral Tablet, BX Rating generic · RxCUI 2001568 | 102 (31%) | 2 | 3 | 0 | 64 |
| methylphenidate HCl 36 MG 24HR Extended Release Oral Tablet, BX Rating generic · RxCUI 2001566 | 100 (30%) | 2 | 3 | 0 | 62 |
| methylphenidate HCl 2.5 MG Chewable Tablet generic · RxCUI 1091389 | 98 (30%) | 4 | 31 | 0 | 68 |
| methylphenidate HCl 10 MG Chewable Tablet generic · RxCUI 1091152 | 96 (29%) | 4 | 31 | 0 | 68 |
| methylphenidate HCl 5 MG Chewable Tablet generic · RxCUI 1091322 | 96 (29%) | 4 | 31 | 0 | 68 |
| methylphenidate HCl 30 MG 50/50 Release 24HR Extended Release Oral Capsule generic · RxCUI 1806179 | 67 (20%) | 4 | 2 | 0 | 43 |
| methylphenidate HCl 20 MG 50/50 Release 24HR Extended Release Oral Capsule generic · RxCUI 1806177 | 66 (20%) | 4 | 1 | 0 | 42 |
| methylphenidate HCl 40 MG 50/50 Release 24HR Extended Release Oral Capsule generic · RxCUI 1806183 | 66 (20%) | 4 | 1 | 0 | 42 |
| methylphenidate HCl 10 MG 50/50 Release 24HR Extended Release Oral Capsule generic · RxCUI 1806195 | 64 (20%) | 4 | 1 | 0 | 40 |
| methylphenidate HCl 60 MG 50/50 Release 24HR Extended Release Oral Capsule generic · RxCUI 1806185 | 62 (19%) | 4 | 2 | 0 | 38 |
| methylphenidate HCl 10 MG 30/70 Release 24HR Extended Release Oral Capsule generic · RxCUI 1806181 | 58 (18%) | 2 | 6 | 0 | 48 |
| methylphenidate HCl 18 MG 24HR Extended Release Oral Tablet, BX Rating generic · RxCUI 2001564 | 58 (18%) | 4 | 2 | 0 | 47 |
| methylphenidate HCl 20 MG 30/70 Release 24HR Extended Release Oral Capsule generic · RxCUI 1806187 | 56 (17%) | 2 | 6 | 0 | 48 |
| methylphenidate HCl 40 MG 30/70 Release 24HR Extended Release Oral Capsule generic · RxCUI 1806191 | 56 (17%) | 2 | 6 | 0 | 48 |
| methylphenidate HCl 30 MG 30/70 Release 24HR Extended Release Oral Capsule generic · RxCUI 1806189 | 55 (17%) | 2 | 5 | 0 | 47 |
| methylphenidate HCl 60 MG 30/70 Release 24HR Extended Release Oral Capsule generic · RxCUI 1806197 | 55 (17%) | 2 | 6 | 0 | 47 |
| methylphenidate HCl 50 MG 30/70 Release 24HR Extended Release Oral Capsule generic · RxCUI 1806193 | 53 (16%) | 4 | 3 | 0 | 45 |
| methylphenidate HCl 72 MG 24HR Extended Release Oral Tablet generic · RxCUI 1995461 | 30 (9%) | 2 | 1 | 0 | 29 |
| methylphenidate HCl 10 MG 40/60 Release 24HR Extended Release Oral Capsule generic · RxCUI 1806200 | 19 (6%) | 2 | 0 | 0 | 16 |
| methylphenidate HCl 30 MG 40/60 Release 24HR Extended Release Oral Capsule generic · RxCUI 1806206 | 19 (6%) | 2 | 0 | 0 | 16 |
| methylphenidate HCl 40 MG 40/60 Release 24HR Extended Release Oral Capsule generic · RxCUI 1806210 | 19 (6%) | 2 | 0 | 0 | 16 |
| methylphenidate HCl 15 MG 40/60 Release 24HR Extended Release Oral Capsule generic · RxCUI 1648183 | 18 (5%) | 2 | 0 | 0 | 15 |
| methylphenidate HCl 20 MG 40/60 Release 24HR Extended Release Oral Capsule generic · RxCUI 1806202 | 18 (5%) | 2 | 0 | 0 | 15 |
| methylphenidate HCl 50 MG 40/60 Release 24HR Extended Release Oral Capsule generic · RxCUI 1806204 | 18 (5%) | 2 | 0 | 0 | 15 |
| methylphenidate HCl 60 MG 40/60 Release 24HR Extended Release Oral Capsule generic · RxCUI 1806208 | 18 (5%) | 2 | 0 | 0 | 15 |
| methylphenidate 10 MG/9HR Transdermal System generic · RxCUI 753436 | 9 (3%) | 4 | 2 | 2 | 8 |
| methylphenidate 15 MG/9HR Transdermal System generic · RxCUI 753438 | 9 (3%) | 4 | 2 | 2 | 8 |
| methylphenidate 20 MG/9HR Transdermal System generic · RxCUI 753440 | 9 (3%) | 4 | 2 | 2 | 8 |
| methylphenidate 30 MG/9HR Transdermal System generic · RxCUI 753441 | 9 (3%) | 4 | 2 | 2 | 8 |
| methylphenidate HCl 63 MG 24HR Extended Release Oral Tablet generic · RxCUI 2605796 | 6 (2%) | 4 | 0 | 0 | 5 |
| methylphenidate hydrochloride 45 MG 24HR Extended Release Oral Tablet generic · RxCUI 2605798 | 6 (2%) | 4 | 0 | 0 | 5 |
| RELEXXII 18 MG 24HR Extended Release Oral Tablet brand · RxCUI 2668496 | 4 (1%) | 3 | 0 | 0 | 4 |
| RELEXXII 27 MG 24HR Extended Release Oral Tablet brand · RxCUI 2668499 | 4 (1%) | 3 | 0 | 0 | 4 |
| RELEXXII 36 MG 24HR Extended Release Oral Tablet brand · RxCUI 2668502 | 4 (1%) | 3 | 0 | 0 | 4 |
| RELEXXII 54 MG 24HR Extended Release Oral Tablet brand · RxCUI 2668505 | 4 (1%) | 3 | 0 | 0 | 4 |
| RELEXXII 72 MG 24HR Extended Release Oral Tablet brand · RxCUI 2052826 | 4 (1%) | 3 | 0 | 0 | 4 |
| Ritalin HCl 10 MG Oral Tablet brand · RxCUI 1091379 | 2 (1%) | 1 | 1 | 0 | 1 |
| Ritalin HCl 20 MG Oral Tablet brand · RxCUI 1091395 | 2 (1%) | 1 | 1 | 0 | 1 |
| Ritalin HCl 5 MG Oral Tablet brand · RxCUI 1091500 | 2 (1%) | 1 | 1 | 0 | 1 |
Counts are formularies (of 328) in the CMS file that list the form, and how many of those apply prior authorization (PA), step therapy (ST) or a quantity limit (QL). Many plans share one formulary, so plan counts in a county will differ.
How to read drug coverage
Tier is the cost-sharing tier the plan assigned the drug in its CMS formulary filing; lower tiers usually cost less. PA = prior authorization, ST = step therapy (try another drug first), QL = quantity limit. Not on formulary means the plan did not list this exact form; the plan may cover another strength or a formulary exception may be possible. Cost sharing is the plan's initial-coverage amount for the tier as filed with CMS; the deductible, the $2,100 annual out-of-pocket cap, the $35 insulin cap and negotiated prices for selected drugs can change what you actually pay. Formularies change during the year; the plan's formulary document and Medicare.gov govern.
What the star rating under each Medicare Advantage plan means
What the star rating means. CMS rates every Medicare Advantage contract (the "H" number in the plan ID — all plans under it share the rating) on a 1-to-5 scale each October, from about 40 measures of care quality, member experience, complaints and appeals, customer service and, for plans with drug coverage, drug safety and pricing. The 2026 rating is largely based on performance measured in 2024.
5 Excellent4 Above average3 Average2 Below average1 Poor
Not rated means CMS published no overall rating — usually a contract too new to be measured or with too few members ("not enough data"); it is not a low score. A 5-star contract can be joined outside the normal enrollment windows (the 5-star Special Enrollment Period, Dec 8 – Nov 30). Medicare.gov flags contracts rated below 3 stars for three years running as low-performing. Stars describe the contract's past performance as CMS measured it; they are not a recommendation, and they do not tell you whether a plan's network, drugs or costs fit you.